These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22340582)

  • 1. Antitumoural hydroxyapatite nanoparticles-mediated hepatoma-targeted trans-arterial embolization gene therapy: in vitro and in vivo studies.
    Li G; Ye L; Pan J; Long M; Zhao Z; Yang H; Tian J; Wen Y; Dong S; Guan J; Luo B
    Liver Int; 2012 Jul; 32(6):998-1007. PubMed ID: 22340582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanism.
    Li G; Kang W; Jin M; Zhang L; Zheng J; Jia K; Ma J; Liu T; Dang X; Yan Z; Gao Z; Xu J
    BMC Cancer; 2019 Nov; 19(1):1126. PubMed ID: 31747895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-alpha in chemotherapy of multidrug-resistant hepatocellular carcinoma.
    Li G; Dong S; Qu J; Sun Z; Huang Z; Ye L; Liang H; Ai X; Zhang W; Chen X
    Liver Int; 2010 Apr; 30(4):585-92. PubMed ID: 19780956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice.
    Dai M; Liu J; Chen DE; Rao Y; Tang ZJ; Ho WZ; Dong CY
    Cancer Gene Ther; 2012 Feb; 19(2):77-83. PubMed ID: 21959967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference].
    Xu JY; Chen LB; Xu JY; Yang Z; Xu RH; Wei HY
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):481-4. PubMed ID: 16772086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo.
    Li D; Ping Y; Xu F; Yu H; Pan H; Huang H; Wang Q; Tang G; Li J
    Biomacromolecules; 2010 Sep; 11(9):2221-9. PubMed ID: 20704346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-arterial gene therapy for hepatocellular carcinoma in a rabbit model.
    Gu T; Li CX; Feng Y; Wang Q; Li CH; Li CF
    World J Gastroenterol; 2007 Apr; 13(14):2113-7. PubMed ID: 17465458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
    Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
    Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
    Xu T; Chen XP; Guo YX; Li D; Lu L; Huan GZ; Zhang WG
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):606-9. PubMed ID: 18844058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.
    Wang W; Zhu F; Wang S; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
    Oncol Rep; 2010 Jul; 24(1):183-8. PubMed ID: 20514460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
    Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
    Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus vector-mediated gene transfer using degradable starch microspheres for hepatocellular carcinoma in rats.
    Shiba H; Okamoto T; Futagawa Y; Misawa T; Yanaga K; Ohashi T; Eto Y
    J Surg Res; 2006 Jun; 133(2):193-6. PubMed ID: 16730258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adenovirus vector expressing MDA-7/IL-24 selectively induces growth arrests and apoptosis in human hepatocellular carcinoma cell lines independent of the state of p53 gene].
    Xue XB; Zheng JW; Wang CJ; Chen K; Hu HY; Hu H; Yu Y; Wu ZD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Sep; 14(9):670-5. PubMed ID: 16995981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes.
    Hu Y; Shen Y; Ji B; Yin S; Ren X; Chen T; Ma Y; Zhang Z; Zhang Y
    Eur J Pharm Biopharm; 2011 Aug; 78(3):320-5. PubMed ID: 21220007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotin-directed assembly of targeted modular lipoplexes and their transfection of human hepatoma cells in vitro.
    Singh A; Ariatti M; Singh M; Hawtrey A; Naidoo R
    Drug Deliv; 2010 Aug; 17(6):426-33. PubMed ID: 20469969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoma-targeted gene delivery using a tumor cell-specific gene regulation system combined with a human liver cell-specific bionanocapsule.
    Kang JH; Oishi J; Kim JH; Ijuin M; Toita R; Jun B; Asai D; Mori T; Niidome T; Tanizawa K; Kuroda S; Katayama Y
    Nanomedicine; 2010 Aug; 6(4):583-9. PubMed ID: 20138242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.